ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,702.55
-0.19%
Dow Jones
42,063.36
0.09%
US Dollar vs MXN
19.4148
0.00%
Brent Oil
74.135
0.00%
Bitcoin
62,572.57
-1.27%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Durect Corp (DRRX)

  7. Durect Corp (DRRX) Noticias

DRRX

Durect (DRRX)

Durect Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DRRX
FechaHoraFuenteTítuloSímboloCompañía
11/09/202411:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRRXDurect Corp
04/09/202415:30PR Newswire (US)DURECT Corporation to Present at the H.C. Wainwright Global Investment ConferenceNASDAQ:DRRXDurect Corp
25/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRRXDurect Corp
14/08/202416:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRRXDurect Corp
13/08/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRRXDurect Corp
12/08/202415:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:DRRXDurect Corp
12/08/202415:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRRXDurect Corp
12/08/202415:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRRXDurect Corp
02/08/202415:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRRXDurect Corp
21/05/202407:00PR Newswire (US)DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
14/05/202415:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRRXDurect Corp
13/05/202415:05PR Newswire (US)DURECT Corporation Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
07/05/202415:30PR Newswire (US)DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
30/04/202406:00PR Newswire (US)DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
27/03/202415:01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:DRRXDurect Corp
20/03/202415:30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
04/03/202406:00PR Newswire (US)DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and CanadaNASDAQ:DRRXDurect Corp
14/02/202415:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DRRXDurect Corp
07/02/202417:48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:DRRXDurect Corp
13/11/202315:05PR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
09/11/202315:30PR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
07/11/202315:01PR Newswire (US)DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on MortalityNASDAQ:DRRXDurect Corp
07/09/202306:00PR Newswire (US)DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated HepatitisNASDAQ:DRRXDurect Corp
31/08/202315:30PR Newswire (US)DURECT Corporation Announces Presentations in Upcoming Investor ConferencesNASDAQ:DRRXDurect Corp
10/08/202315:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRRXDurect Corp
09/08/202315:05PR Newswire (US)DURECT Corporation Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:DRRXDurect Corp
03/08/202315:30PR Newswire (US)DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business UpdateNASDAQ:DRRXDurect Corp
21/07/202309:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:DRRXDurect Corp
20/07/202307:00PR Newswire (US)DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:DRRXDurect Corp
23/06/202316:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DRRXDurect Corp
 Showing the most relevant articles for your search:NASDAQ:DRRX

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
CCOM
US30
US 30
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NYSE
JPM
JP Morgan Chase
NYSE
VZ
Verizon Communications
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados